New applications of myocardial perfusion imaging

Texas Heart Institute Journal

Volumn 23, Issue 2, 1996, Pages 122-127

  DePuey, E Gordon ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Coronary disease radionuclide imaging; deoxyglucose diagnostic use; fluorine radioisotopes diagnostic use; gated blood pool imaging; heart radionuclide imaging; radionuclide angiography statistics and numerical data; technetium Tc 99m sestamibi diagnostic use; thallium radioisotopes diagnostic use; tomography, emission computed, single photon

Indexed keywords

DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEART MUSCLE PERFUSION; HUMAN; MYOCARDIAL DISEASE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY CIRCULATION; CORONARY DISEASE; HEART; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL STUNNING; RADIONUCLIDE ANGIOGRAPHY; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029992962     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Marcassa C, Marzullo P, Parodi O, Sambuceti G, L'Abbate A. A new method for noninvasive quantitation of segmental myocardial wall thickening using technetium-99m 2-methoxy-isobutyl-isonitrile scintigraphy - results in normal subjects. J Nucl Med 1990;31:173-7.
2. Cooke CD, Garcia EV, Cullom SJ, Faber TL, Pettigrew RI. Determining the accuracy of calculating systolic wall thickening using a fast Fourier transform approximation: a simulation study based on canine and patient data. J Nucl Med 1994;35:1185-92.
3. DePuey EG, Nichols K, Dobrinsky C. Left ventricular ejection fraction from gated technetium-99m-sestamibi SPECT. J Nucl Med 1993;34:1871-6.
4. Chua T, Kiat H. Germano G, Maurer G, Van Train K, Friedman J, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994;23:1107-14.
5. DePuey EG, Rozanski A. Using gated Tc-99m sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 1995;36:952-5.
6. Pryor DB, Harrell FE Jr, Lee KL, Califf RM, Rosati RA. An improving prognosis over time in medically treated patients with coronary artery disease. Am J Cardiol 1983;52:444-8.
7. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6.
8. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation 1991;83: 26-37.
9. Favaro L, Masini F, Serra W, Gavaruzzi G, Benecchi G, Tagliavini S, et al. Thallium 201 for detection of viable myocardium: comparison of different reinjection protocols. J Nucl Cardiol 1994;1:515-21.
10. Lomboy CT, Schulman DS, Grill HP, Flores AR, Orie JE, Granato JE. Rest-redistribution thallium-201 scintigraphy to determine myocardial viability early after myocardial infarction. J Am Coll Cardiol 1995;25:210-7.
11. Bisi G, Sciagra R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282-9.
12. Udelson JE, Coleman PS. Metherall J, Pandian NG, Gomez AR, Griffith JL, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994;89:2552-61.
13. Leichner PK, Morgan HT, Holdeman KP, Harrison KA, Valentino F, Lexa R, et al. SPECT imaging of fluorine-18. J Nucl Med 1995;36:1472-5.
14. Bax JJ, Visser FC, van Lingen A, Visser CA, Teule GJJ. Myocardial F-18 fluorodeoxyglucose imaging by SPECT. Clin Nucl Med 1995;20:486-90.
15. Kelly MJ. Fluorine 18-labeled fluorodeoxyglucose myocardial scintigraphy with Anger gamma cameras for assessing myocardial viability. J Nucl Cardiol 1995;2:360-5.